Tag

Catalent

naloxone

Catalent Signs Agreement to Manufacture Naloxone Nasal Spray
coronavirus vaccine

Catalent, AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine
Vaccine healthcare

Catalent Signs Agreement to Manufacture Lead COVID-19 Vaccine Candidate
merger & acquisition

Catalent to Acquire MaSTherCell Global for $315 Million
handshake

Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy
merger & acquisition

Catalent Acquires Paragon Bioservices, Inc. for $1.2 Billion
merger & acquisition

Catalent to Acquire Paragon Bioservices, Inc. for $1.2 Billion
CEO

Catalent Names Alessandro Maselli President, CEO
Digital

Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc
research & development

Catalent Completes Accucaps Acquisition to Expand Softgel Development and Manufacturing Capabilities and Capacity
pharmaceuticals

Catalent Acquires Accucaps to Expand Softgel Development and Manufacturing Capabilities and Capacity